Oral antiplatelet agents for the management of acute coronary syndromes: A review for nurses and allied healthcare professionals
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the American Association of Nurse Practitioners"
DOI: 10.1002/2327-6924.12438
Abstract: Purpose We review the use of oral antiplatelet (OAP) therapies in acute coronary syndrome (ACS) management for nurse practitioners (NPs), focusing on current guideline recommendations. Data sources Treatment guidelines and clinical articles from PubMed. Conclusions… read more here.
Keywords: clopidogrel; ticagrelor; antiplatelet; management ... See more keywords
Mesoporous Silica Nanotraps for Mitigating Bleeding Risk From ‘Irreversible’ Antiplatelet Drugs
Sign Up to like & getrecommendations! Published in 2025 at "Advanced Materials"
DOI: 10.1002/adma.202501576
Abstract: The severe bleeding complications of long‐term antiplatelet therapy limit its broader application in the treatment or prevention of thrombosis‐associated diseases. This risk is particularly serious when facing emergency surgeries where rapid restoration of normal platelet… read more here.
Keywords: mesoporous silica; antiplatelet; irreversible antiplatelet; nanotraps mitigating ... See more keywords
Percutaneous coronary intervention with drug‐coated balloon‐only strategy combined with single antiplatelet treatment in patients at high bleeding risk: Single center experience of a novel concept
Sign Up to like & getrecommendations! Published in 2023 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30558
Abstract: At least 1 month of dual antiplatelet therapy is required after coronary stenting. The aim of this all‐comers retrospective registry study was to assess the efficacy and safety of percutaneous coronary intervention (PCI) using drug‐coated… read more here.
Keywords: percutaneous coronary; coated balloon; coronary intervention; drug coated ... See more keywords
Cost‐effectiveness analysis of 30‐month vs 12‐month dual antiplatelet therapy with clopidogrel and aspirin after drug‐eluting stents in patients with acute coronary syndrome
Sign Up to like & getrecommendations! Published in 2017 at "Clinical Cardiology"
DOI: 10.1002/clc.22756
Abstract: Continuation of dual antiplatelet therapy (DAPT) beyond 1 year reduces late stent thrombosis and ischemic events after drug‐eluting stents (DES) but increases risk of bleeding. We hypothesized that extending DAPT from 12 months to 30… read more here.
Keywords: dapt; antiplatelet; continuation; dapt continuation ... See more keywords
Role of P2Y12 Receptor in Thrombosis.
Sign Up to like & getrecommendations! Published in 2017 at "Advances in experimental medicine and biology"
DOI: 10.1007/5584_2016_123
Abstract: P2Y12 receptor is a 342 amino acid Gi-coupled receptor predominantly expressed on platelets. P2Y12 receptor is physiologically activated by ADP and inhibits adenyl cyclase (AC) to decrease cyclic AMP (cAMP) level, resulting in platelet aggregation.… read more here.
Keywords: antiplatelet; thrombosis; role; receptor ... See more keywords
[Oral anticoagulation and antiplatelet therapy in patients with atrial fibrillation after coronary interventions].
Sign Up to like & getrecommendations! Published in 2019 at "Herz"
DOI: 10.1007/s00059-019-4811-x
Abstract: Dual antiplatelet therapy (DAPT) is the cornerstone of maintenance medication following elective percutaneous coronary intervention and also after acute coronary syndrome (ST-elevation myocardial infarction, non-ST-elevation myocardial infarction, unstable angina pectoris); however, DAPT is not sufficient… read more here.
Keywords: atrial fibrillation; antiplatelet; antiplatelet therapy; therapy ... See more keywords
Safety and efficacy of a pre-treatment antiplatelet regimen of unruptured intracranial aneurysms: a single-center experience
Sign Up to like & getrecommendations! Published in 2020 at "Neuroradiology"
DOI: 10.1007/s00234-020-02387-y
Abstract: Purpose Endovascular treatment of unruptured intracranial aneurysms with stent-assisted coiling or flow diverter stents requires a prophylactic antiplatelet premedication to avoid thrombo-embolic complications. Guidelines for optimal antiplatelet regimens are poorly defined. The aim of this… read more here.
Keywords: antiplatelet; treatment; intracranial aneurysms; morbidity ... See more keywords
Antiplatelet Therapy is Associated with Stent Patency After Iliocaval Venous Stenting
Sign Up to like & getrecommendations! Published in 2018 at "CardioVascular and Interventional Radiology"
DOI: 10.1007/s00270-018-2062-5
Abstract: PurposeTo examine the effectiveness of antithrombotic medications to prevent venous stent malfunction for iliocaval occlusive disease.Materials and MethodsA retrospective analysis was performed on 62 patients who underwent technically successful endovascular iliocaval stent placement between May… read more here.
Keywords: patency; antiplatelet; iliocaval venous; venous stenting ... See more keywords
Long-term outcome of tailored antithrombotic therapy based on platelet function testing in patients undergoing percutaneous coronary intervention: a 5-year retrospective cohort study.
Sign Up to like & getrecommendations! Published in 2025 at "Heart and vessels"
DOI: 10.1007/s00380-025-02584-w
Abstract: Dual antiplatelet therapy is the standard therapy for the secondary prevention of acute and chronic coronary syndromes in patients undergoing percutaneous coronary intervention (PCI). The introduction of more potent antiplatelet agents and understanding of prognostic… read more here.
Keywords: patients undergoing; therapy; antiplatelet; platelet function ... See more keywords
Antiplatelet therapy in acute myocardial infarction complicated by cardiogenic shock
Sign Up to like & getrecommendations! Published in 2025 at "Clinical Research in Cardiology"
DOI: 10.1007/s00392-025-02619-2
Abstract: Coronary revascularization represents a cornerstone in the treatment of infarct-related cardiogenic shock (CS). Early and effective antithrombotic therapy is critical and has been shown to improve mortality in most patients with acute coronary syndrome. Achieving… read more here.
Keywords: therapy; antiplatelet; cardiogenic shock; myocardial infarction ... See more keywords
Evaluation and optimization of prescribed concomitant antiplatelet and anticoagulation therapy centrally managed by an anticoagulation management service
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Thrombosis and Thrombolysis"
DOI: 10.1007/s11239-020-02207-3
Abstract: Patients on long-term anticoagulation combined with antiplatelet therapy have an increased risk of bleeding compared to patients on anticoagulation alone. The aim of this study was to evaluate the appropriateness of antiplatelet therapy in patients… read more here.
Keywords: anticoagulation; risk; long term; antiplatelet ... See more keywords